News

Lundbeck and LifeHealth have entered into a definitive agreement under which Lundbeck acquires all shares of LifeHealth, the holder of Xenazine rights. The deal is an all-cash transaction

Lexicon has initiated the phase-II clinical trial of LX1032, an oral drug candidate for managing gastrointestinal symptoms associated with carcinoid syndrome. LX1032 is designed to reduce serotonin production

Diabetica Research Solutions (DRS) has introduced drsi Restore! Energy, which reportedly helps diabetics and pre-diabetics to experience balanced energy and stamina.   The company said that drsi is

Repros Therapeutics provides a further update on the clinical development of Proellex 25mg and 12.5mg doses. Repros’ recent decision to discontinue the use of the Proellex 50mg dose

Absorption Systems has acquired Perry Scientific, an in-vivo toxicology and pharmacokinetics testing company, located in San Diego, California. Patrick Dentinger, President and CEO of Absorption Systems, said: “The

Boehringer Ingelheim announced that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for Viramune (nevirapine) in the treatment of patients with HIV.

NXP has announced collaboration with Siemens on an RFID-based supply chain pharmaceutical project designed to improve efficiency from manufacture to retail. Using NXP’s Application and System Center (ASC,

KDH Systems has introduced PatientLocate, to change the paradigm of clinical trial patient recruitment. By automating the process of matching inclusion/exclusion criteria directly through hospital information systems, it

Kofax, a provider of Intelligent Capture and Exchange solutions, has signed a $350,000 contract with EDCO Group. EDCO would utilize Kofax software to automate the processing of millions